Juntendo University · Graduate School of Medicine / Faculty of Medicine

Research keywordstype 2 diabetes・pioglitazone・macrovascular risk・hepatic glucose flux・insulin clearance・polyol pathway activity

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Yoshii H, OnumaT, Yamazaki T, Watada H, Matsuhisa M, Matsumoto M, Kitagawa K, Kitakaze M, Yamasaki Y, Kawamori R, the PROFIT-J Study Group: Effets of pioglitazone on macrovascular events in patients with type 2 diabetes mellitus at high risk of stroke: The PROFIT-J study. J Atheroscler Thromb, 2014 Jun 25;21(6):563-73. Epub 2014 Jan 29.2014
• Yoshii H, Lam TK, Gupta N, Goh T, Haber CA, Uchino H, Kim T, Chong V, Shah K, Fantus IG, Mari A, Kawamori R, Giacca A: Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux. Am J Physiol Endocrinol Metab, 290(6), E1089-97, 2006 Jan 3 ;2006
• Yoshii H, Uchino H, Ohmura C, Watanabe K, Tanaka Y, Kawamori R: Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity. Diabetes Res Clin Pract. 51:115-23, 20012001

• Official profile